AI R&D Drug Startup XtalPi raises $318M
XtalPi, an Artificial Intelligence (AI) drug discovery and development technology company, announced today an oversubscribed Series C funding round of $318.8 million
drug discovery
Curi Bio launches Mantarray Platform for analysis of 3D Engineered Muscle Tissues
Curi Bio launches Mantarray Platform for analysis of 3D engineered muscle tissue in the development of new therapeutics
Recursion Pharmaceuticals $121 million Series C for AI drug discovery
Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors. The funds will be invested to continue building Recursion’s AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology. Recursion […]
Schrödinger closes USD 85 million funding round from Gates Foundation and others
The Bill and Melinda Gates Foundation and WuXi AppTec’s Corporate Venture Fund have led an $85 million funding round into Schrödinger. The company produces a computational platform for drug discovery, which it also uses for its own research.